Evolus Vs. Neurogene Industry Stock Comparison

Sell

13

EOLS
Evolus

Last Price:

12.13

Seasonality Move:

49.62%

Sell

1

NGNE
Neurogene

Last Price:

34.67

Seasonality Move:

50.43%

Sell

13

Evolus (EOLS) is a Sell

Is Evolus a Buy, Sell or Hold?

The current Evolus [EOLS] share price is $12.11. The Score for EOLS is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
EOLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

1

Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

EOLS Stock Price Chart

What is Evolus's stock price today?

The Evolus share price today is $12.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EOLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

The Neurogene share price today is $34.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

EOLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.07	Sell
Relative Strength Index (14 RSI):	26.8	Sell
Chaikin Money Flow:	1098729	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(13.73 - 17.25)	Sell
Bollinger Bands (100):	(12.39 - 16.57)	Sell

NGNE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.55	Sell
Relative Strength Index (14 RSI):	35.74	Sell
Chaikin Money Flow:	-452975	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(41.4 - 61.5)	Sell
Bollinger Bands (100):	(34.32 - 50.52)	Sell

EOLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	13.32	Sell
20-day SMA:	15.12	Sell
50-day SMA:	15.88	Sell
200-day SMA:	13.72	Sell
8-day EMA:	13.18	Sell
20-day EMA:	14.56	Sell
50-day EMA:	15.19	Sell
200-day EMA:	13.64	Sell

NGNE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	53.3	Sell
20-day SMA:	51.47	Sell
50-day SMA:	46.76	Sell
200-day SMA:	38.99	Sell
8-day EMA:	47.13	Sell
20-day EMA:	50.2	Sell
50-day EMA:	47.47	Sell
200-day EMA:	38.44	Sell

Evolus Earnings Growth & EOLS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $0.34 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Evolus Technical Analysis

	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15
	Nov
	04	05	06	07	08	11	12	13	14	15
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15
	Nov
	04	05	06	07	08	11	12	13	14	15
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):